🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/10/2023 | 99,99 | 103,36 | 99,99 | 102,67 | +2,23% | 3,37% | 12.467.500 |
| 19/10/2023 | 101,66 | 101,73 | 99,14 | 100,43 | -1,53% | 2,55% | 7.647.600 |
| 18/10/2023 | 104,11 | 104,46 | 101,91 | 101,99 | -2,09% | 2,45% | 7.136.400 |
| 17/10/2023 | 104,00 | 104,49 | 103,15 | 104,17 | +0,03% | 1,29% | 5.827.200 |
| 16/10/2023 | 104,20 | 105,37 | 104,06 | 104,14 | +0,12% | 1,26% | 6.473.500 |
| 13/10/2023 | 103,61 | 104,52 | 102,78 | 104,01 | +0,41% | 1,68% | 5.787.500 |
| 12/10/2023 | 103,52 | 103,95 | 102,93 | 103,59 | +0,13% | 0,99% | 5.124.000 |
| 11/10/2023 | 104,00 | 104,21 | 102,85 | 103,46 | -0,14% | 1,31% | 5.375.100 |
| 10/10/2023 | 104,32 | 104,46 | 103,16 | 103,61 | -0,85% | 1,25% | 7.177.200 |
| 09/10/2023 | 103,50 | 105,19 | 103,31 | 104,50 | +0,60% | 1,82% | 5.061.100 |
| 06/10/2023 | 103,73 | 104,43 | 102,92 | 103,88 | +0,27% | 1,46% | 6.854.900 |
| 05/10/2023 | 102,36 | 103,71 | 102,34 | 103,60 | +1,40% | 1,34% | 6.449.100 |
| 04/10/2023 | 101,58 | 102,43 | 101,33 | 102,17 | +0,39% | 1,08% | 6.720.500 |
| 03/10/2023 | 102,24 | 102,44 | 100,92 | 101,77 | -0,76% | 1,49% | 5.924.000 |
| 02/10/2023 | 102,83 | 102,83 | 101,35 | 102,55 | -0,39% | 1,44% | 7.079.700 |
| 29/09/2023 | 104,36 | 104,68 | 102,71 | 102,95 | -1,29% | 1,89% | 7.232.700 |
| 28/09/2023 | 104,57 | 104,97 | 103,78 | 104,30 | +0,35% | 1,14% | 4.758.800 |
| 27/09/2023 | 105,45 | 105,52 | 103,30 | 103,94 | -1,38% | 2,11% | 5.635.500 |
| 26/09/2023 | 105,12 | 106,55 | 105,11 | 105,39 | -0,43% | 1,37% | 5.400.500 |
| 25/09/2023 | 106,05 | 106,19 | 105,11 | 105,84 | -0,47% | 1,02% | 6.052.200 |
| 22/09/2023 | 107,22 | 107,22 | 105,96 | 106,34 | -0,37% | 1,18% | 5.027.200 |
| 21/09/2023 | 107,27 | 107,88 | 106,42 | 106,73 | -0,54% | 1,36% | 5.856.600 |
| 20/09/2023 | 108,21 | 108,40 | 107,25 | 107,31 | -0,05% | 1,06% | 4.593.600 |
| 19/09/2023 | 107,65 | 108,18 | 106,91 | 107,36 | -0,43% | 1,18% | 5.818.300 |
| 18/09/2023 | 107,77 | 107,94 | 106,85 | 107,82 | +0,28% | 1,01% | 3.911.300 |
| 15/09/2023 | 108,12 | 108,93 | 107,26 | 107,52 | -0,67% | 1,54% | 9.639.000 |
| 14/09/2023 | 107,69 | 108,51 | 106,96 | 108,24 | +0,40% | 1,44% | 6.872.400 |
| 13/09/2023 | 108,98 | 109,67 | 107,67 | 107,81 | -1,11% | 1,84% | 6.761.500 |
| 12/09/2023 | 108,42 | 109,48 | 107,55 | 109,02 | +0,39% | 1,78% | 4.605.400 |
| 11/09/2023 | 109,33 | 109,44 | 108,34 | 108,60 | -0,41% | 1,01% | 5.069.300 |